Hera BioLabs Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 16

Employees
  • Latest Deal Type

  • Series A3

  • Latest Deal Amount

  • $1.07M

  • Investors

  • 4

Hera BioLabs General Information

Description

Provider of pre-clinical drug development services intended to develop cell-line modification and animal model creation. The company's service is offered through a contract research organization utilizing revolutionary gene-editing technologies to create improved preclinical models, performing cell engineering and in vitro and in vivo oncology studies for clients, enabling researchers to discover drugs and treat diseases.

Contact Information

Website
www.herabiolabs.com
Formerly Known As
Hera Testing Laboratories
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Primary Office
  • 2277 Thunderstick Drive
  • Suite 500
  • Lexington, KY 40505
  • United States
+1 (859) 000-0000

Hera BioLabs Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hera BioLabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A3) 03-Aug-2020 $1.07M 00.000 000.00 Completed Generating Revenue
6. Debt - PPP 03-May-2020 00.000 Completed Generating Revenue
5. Early Stage VC (Series A2) 25-Apr-2018 00000 00.000 00.000 Completed Generating Revenue
4. Grant 19-Sep-2017 000.00 00.00 Completed Generating Revenue
3. Grant 01-Jan-2017 00.000 00.00 Completed Generating Revenue
2. Early Stage VC (Series A1) 26-Sep-2016 $700K $1.8M 000 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Feb-2015 $1.1M $1.1M 00.00 Completed Generating Revenue
To view Hera BioLabs’s complete valuation and funding history, request access »

Hera BioLabs Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A3 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 2,543,387 $0.000100 6% $0.36 $0.36 1x $0.36 8.88%
Series A 4,443,037 $0.000100 6% $0.28 $0.28 1x $0.28 15.52%
To view Hera BioLabs’s complete cap table history, request access »

Hera BioLabs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of pre-clinical drug development services intended to develop cell-line modification and animal model creation.
Drug Discovery
Lexington, KY
16 As of 2022
00.000
00.00 0000-00-00
00000000000 00.000

00000

or in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
0000000000000
Woodbine, MD
00 As of 0000
00000
00000000000 00000

000000

nderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
Exton, PA
00 As of 0000
00.000
000000000 - 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hera BioLabs Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Noble Life Sciences Venture Capital-Backed Woodbine, MD 00 00000 00000000000 00000
000000 000000000 Venture Capital-Backed Exton, PA 00 00.000 000000000 - 00.000
0000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 00 0000 0000000000 0 0000
000000000 00000000 Private Equity-Backed Nottingham, United Kingdom 000 000000000
0000000 00000 0000 Formerly PE-Backed Wilmington, MA 00000 00000 00000000000 00000
You’re viewing 5 of 25 competitors. Get the full list »

Hera BioLabs Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Hera BioLabs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210092942-A1 Novel immunodeficient rat for modeling human cancer Inactive 31-Mar-2017 00000000000
US-20170112108-A1 Genetically modified non-human mammals having modified liver cells and/or tissue and methods of making same Inactive 22-Oct-2015 00000000000
EP-2971006-A4 Reproducible method for testis-mediated genetic modification (tgm) and sperm-mediated genetic modification (sgm) Inactive 15-Mar-2013 00000000000 0
EP-2971006-A2 Reproducible method for testis-mediated genetic modification (tgm) and sperm-mediated genetic modification (sgm) Inactive 15-Mar-2013 00000000000
US-20160046959-A1 Reproducible method for testis-mediated genetic modification (tgm) and sperm-mediated genetic modification (sgm) Inactive 15-Mar-2013 C12N15/8509
To view Hera BioLabs’s complete patent history, request access »

Hera BioLabs Executive Team (4)

Name Title Board Seat Contact Info
Michael Schlosser Ph.D Chief Executive Officer & Board Member
Eric Ostertag Ph.D Founder & Chairman
You’re viewing 2 of 4 executive team members. Get the full list »

Hera BioLabs Board Members (3)

Name Representing Role Since
Christopher Young Self Board Member 000 0000
Eric Ostertag Ph.D Self Founder & Chairman 000 0000
Michael Schlosser Ph.D Hera BioLabs Chief Executive Officer & Board Member 000 0000
To view Hera BioLabs’s complete board members history, request access »

Hera BioLabs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hera BioLabs Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bluegrass Angels Angel Group Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Enterprise Angels Community Fund Angel Group Minority 000 0000 000000 0
To view Hera BioLabs’s complete investors history, request access »

Hera BioLabs Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 01-Jan-2018 0000000000 Biotechnology
To view Hera BioLabs’s complete acquisitions history, request access »

Ready to get started?

Request a free trial